Evidence map›Paper›PMID 31653874›Full record

ArticleScientific reports2019

Development and application of affordable SNP typing approaches to genotype Mycobacterium tuberculosis complex strains in low and high burden countries.

Irving Cancino-Muñoz, Ana Gil-Brusola, Manuela Torres-Puente, Carla Mariner-Llicer, John Dogba, Victor Akinseye, Kehinde Adesokan, Ayi Kwaghe, Francis Ejeh, Simeon Cadmus and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Irving Cancino-MuñozInstituto de Biomedicina de Valencia (IBV-CSIC), Valencia, Spain.
Ana Gil-BrusolaHospital Universitari I Politècnic La Fe, Microbiology Department, Valencia, Spain.
Manuela Torres-PuenteInstituto de Biomedicina de Valencia (IBV-CSIC), Valencia, Spain.
Carla Mariner-LlicerInstituto de Biomedicina de Valencia (IBV-CSIC), Valencia, Spain.
John DogbaUniversity of Ibadan, Department of Veterinary Public Health & Preventive Medicine, Ibadan, Nigeria.
Victor AkinseyeUniversity of Ibadan, Department of Veterinary Public Health & Preventive Medicine, Ibadan, Nigeria.
Kehinde AdesokanUniversity of Ibadan, Department of Veterinary Public Health & Preventive Medicine, Ibadan, Nigeria.
Ayi KwagheFederal Ministry of Agriculture and Rural Development, Department of Veterinary and Pest Control Services, Garki, Nigeria.
Francis EjehUniversity of Maiduguri, Department of Veterinary Microbiology, Maiduguri, Nigeria.
Simeon CadmusUniversity of Ibadan, Department of Veterinary Public Health & Preventive Medicine, Ibadan, Nigeria.
Iñaki ComasInstituto de Biomedicina de Valencia (IBV-CSIC), Valencia, Spain. icomas@ibv.csic.es.ORCID http://orcid.org/0000-0001-5504-9408

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Mycobacterium tuberculosis complex (MTBC) comprises the species that causes tuberculosis (TB) which affects 10 million people every year. A robust classification of species, lineages, and sub-lineages is important to explore associations with drug resistance, epidemiological patterns or clinical outcomes. We present a rapid and easy-to-follow methodology to classify clinical TB samples into the main MTBC clades. Approaches are based on the identification of lineage and sub-lineage diagnostic SNP using a real-time PCR high resolution melting assay and classic Sanger sequencing from low-concentrated, low quality DNA. Thus, suitable for implementation in middle and low-income countries. Once we validated our molecular procedures, we characterized a total of 491 biological samples from human and cattle hosts, representing countries with different TB burden. Overall, we managed to genotype ~95% of all samples despite coming from unpurified and low-concentrated DNA. Our approach also allowed us to detect zoonotic cases in eight human samples from Nigeria. To conclude, the molecular techniques we have developed, are accurate, discriminative and reproducible. Furthermore, it costs less than other classic typing methods, resulting in an affordable alternative method in TB laboratories.

Indexed as

Bacterial Typing TechniquesGenotypeGeographyHumansMycobacterium tuberculosisNigeriaPhylogenyPolymorphism, Single NucleotideSequence Analysis, DNASpain

Identifiers

PMID31653874
PMCPMC6814786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.